DOXORUBICIN for Soft tissue sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 302 adverse event reports in the FDA FAERS database where DOXORUBICIN was used for Soft tissue sarcoma.

Most Reported Side Effects for DOXORUBICIN

Side Effect	Reports	%	Deaths	Hosp.
Febrile neutropenia	8,844	10.7%	1,075	5,491
Off label use	7,858	9.5%	1,712	2,385
Disease progression	6,165	7.5%	1,384	865
Neutropenia	5,891	7.1%	927	2,104
Drug ineffective	4,598	5.6%	1,342	1,068
Pyrexia	3,697	4.5%	482	2,503
Thrombocytopenia	3,638	4.4%	645	1,330
Anaemia	3,601	4.4%	555	1,566
Product use in unapproved indication	3,502	4.2%	821	978
Nausea	2,925	3.5%	279	1,405
Sepsis	2,740	3.3%	1,481	1,198
Pneumonia	2,611	3.2%	839	1,521
Death	2,515	3.0%	2,514	299
Diarrhoea	2,330	2.8%	403	1,216
Vomiting	2,279	2.8%	310	1,233